All entries for: CRISPR Therapeutics

February 12, 2026

CRISPR Therapeutics

Neutral Outlook

Switzerland
201-500 employees

Recent executive and agency actions have advanced various most-favored-nation (“MFN”)-type pricing concepts that could materially affect the prices we may obtain for any products, if approved.

February 28, 2025

CRISPR Therapeutics

Layoffs

Switzerland
201-500 employees

Laying off an undisclosed number of employees.

Disease Area: Chronic Disease, Multiple, Oncology, Rare Diseases
Drug Type: Biologic, Small Molecule
Scroll to Top